Therapeutically induced focal angiogenesis will provide a unique approach to rescue ischemic injured brain tissue, and improve neurological outcome. The associated adverse effects such as vascular leakage and edema compromise VEGF as a therapeutic agent for stroke intervention. Developmental endothelial locus-1 (Del-1) is a novel angiomatrix protein, which has been demonstrated to stimulate a potent angiogenic response, and promote functional recovery in hind limb and cardiac ischemia in vivo. Whether Del-1 is expressed in the normal or ischemic brain, and what functions Del-1 plays in the ischemic brain has not been investigated. The effect of Del-1 hyperstimulation in the brain is unknown. Our general hypothesis is that Del-1 overexpression through gene transfer, compared to VEGF overexpression, induces functional cerebral angiogenesis, but with retained barrier function, thereby improving neurological outcome. Specifically, we will determine whether overexpression of Del-1 by gene transfer stimulates functional brain angiogenesis, and reduces neurological deficits in a mouse model of transient middle cerebral artery occlusion (tMCAO). Microvessel counting, BBB permeability, focal cerebral blood flow, and tight junction protein ZO-1 expression will be used to assess functional neovessel formation. We will also investigate the mechanisms by which Del-1 induces focal angiogenesis in the mouse brain. Del-1 has an Arg-Gly-Asp motif and has been shown to mediate migration of endothelial cells through integrin binding. The primary pathways of Del-1 induced angiogenesis will be investigated by using avB3 and avB5 integrin knockout mice, as well as a series of function-blocking antibodies, and rescue strategies. Whether transcription factor HoxD3, which is a potent proangiogenic factor, is required for Del-1 induced angiogenesis will also be examined by using HoxDS RNA silencing. The results from this study may lead to the development of a clinically significant stroke therapy. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21NS053943-01A1
Application #
7142127
Study Section
Special Emphasis Panel (ZRG1-BINP-L (01))
Program Officer
Jacobs, Tom P
Project Start
2006-05-01
Project End
2008-04-30
Budget Start
2006-05-01
Budget End
2007-04-30
Support Year
1
Fiscal Year
2006
Total Cost
$192,420
Indirect Cost
Name
University of California San Francisco
Department
Neurology
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Chen, Yongmei; Hao, Qi; Kim, Helen et al. (2009) Soluble endoglin modulates aberrant cerebral vascular remodeling. Ann Neurol 66:19-27
Zhu, Wei; Fan, Yongfeng; Hao, Qi et al. (2009) Postischemic IGF-1 gene transfer promotes neurovascular regeneration after experimental stroke. J Cereb Blood Flow Metab 29:1528-37
Fan, Yongfeng; Zhu, Wei; Yang, Michael et al. (2008) Del-1 gene transfer induces cerebral angiogenesis in mice. Brain Res 1219:1-7
Zhu, Wei; Fan, Yongfeng; Frenzel, Tim et al. (2008) Insulin growth factor-1 gene transfer enhances neurovascular remodeling and improves long-term stroke outcome in mice. Stroke 39:1254-61
Zhu, Wei; Khachi, Steve; Hao, Qi et al. (2008) Upregulation of EMMPRIN after permanent focal cerebral ischemia. Neurochem Int 52:1086-91